An observational study in COVID-19 and Acute Kidney Injury, sponsored by Instituto Nacional de Enfermedades Respiratorias. Completed at 1 site in Mexico. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2024-06-24.
Sponsored by Instituto Nacional de Enfermedades Respiratorias · Observational
The goal of this observational study was to identify subphenotypes of acute kidney injury patients with COVID-19, and the investigators analyzed their impact on mortality. The study included demographic and clinical variables of the participants. The implementation of Machine Learning algorithms and Artificial Intelligence methods are used, and some specific implementations were designed for the analysis, where each group was characterized by traditional statistical methods.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 2,934 is above the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →Instituto Nacional de Enfermedades Respiratorias is the lead sponsor of 16 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with acute kidney injury and COVID-19
Exclusion Criteria:
clustering
Subphenotypes of acute kidney injury in patients
Number of acute kidney injury subphenotypes in patients with COVID-19
Time frame: Through study completion, an average of one month
Mortality of acute kidney injury patients
Differences between mortality rates in acute kidney injury subphenotypes of patients with COVID-19
Time frame: Through study completion, an average of one month
Severity of acute kidney injury patients
Differences between severity stages in acute kidney injury subphenotypes of patients with COVID-19
Time frame: Through study completion, an average of one month
Non-recovery in acute kidney injury patients
Differences between non recovery rates in acute kidney injury subphenotypes of patients with COVID-19
Time frame: Through study completion, an average of one month
Renal replacement therapy requirement in acute kidney injury patients
Differences between renal replacement therapy requirement rates in acute kidney injury subphenotypes of patients with COVID-19
Time frame: Through study completion, an average of one month
Length of stay of acute kidney injury patients
Differences in-hospital length of stay in acute kidney injury subphenotypes of patients with COVID-19.
Time frame: Through study completion, an average of one month
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto Nacional de Enfermedades Respiratorias